Effects of lycopene on the induction of foam cell formation by modified LDL

American Journal of Physiology - Endocrinology and Metabolism

Volumn 293, Issue 6, 2007, Pages

  Napolitano, Mariarosaria ^a   De Pascale, Clara ^b   Wheeler Jones, Caroline ^b   Botham, Kathleen M ^b   Bravo, Elena ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Cytokines; Low density lipoprotein; Macrophage; Scavenger receptors

Indexed keywords

CHOLESTEROL ESTER; INTERLEUKIN 10; INTERLEUKIN 1BETA; LOW DENSITY LIPOPROTEIN; LYCOPENE; SCAVENGER RECEPTOR; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ACETYLATION; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; FOAM CELL; HUMAN; HUMAN CELL; LIPOGENESIS; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, CD36; CAROTENOIDS; CELL LINE; CELLS, CULTURED; CHOLESTEROL; CHOLESTEROL ESTERS; ENDOCYTOSIS; FOAM CELLS; GENE EXPRESSION; HUMANS; INTERLEUKIN-10; INTERLEUKIN-1BETA; LIPID METABOLISM; LIPOPROTEINS, LDL; MACROPHAGES; RECEPTORS, SCAVENGER; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCAVENGER RECEPTORS, CLASS A; SCAVENGER RECEPTORS, CLASS B; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 37149000087     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00315.2007     Document Type: Article

References (48)

1. Albertini R, Moratti R, DeLuca G. Oxidation of low-density lipoprotein in atherosclerosis from basic biochemistry to clinical studies. Curr Mol Med 2: 579-592, 2002.
2. Amundson DM, Zhou M. Fluorometric method for the enzymatic determination of cholesterol. J Biochem Biophys Methods 38: 43-52, 1999.
3. Arap L, Steck S. Lycopene and cardiovascular disease. Am J Clin Nutr Suppl 71: 1691S-1695S, 2000.
4. Asmis R, Jelk J. Large variation in human foam cell formation in individuals: a fully autologous in vitro assay based on the quantitiative analysis of cellular neutral lipids. Atherosclerosis 148: 243-253, 2000.
5. Asmis R, Jelk J. Vitamin E supplementation of human macrophages prevents neither foam cell formation nor increased susceptibility of foam cells to lysis by oxidized LDL. Arterioscler Thromb Vasc Biol 20: 2078-2086, 2000.
6. Basu SK, Goldstein JL, Brown MS. Receptor-mediated endocytosis of low density lipoprotein in cultured cell. Meth Enzymol 46: 241-261, 1986.
7. Batt KV, Patel L, Botham KM, Suckling KE. Chylomicron remnants and low density lipoprotein have differential effects on the expression of mRNA for genes involved in human macrophage formation. J Mol Med 82: 449-458, 2004.
8. Blum A, Monir M, Wirsansky I, Ben-Arzi S. The beneficial effects of tomatoes. Eur J Int Med 16: 402-404, 2005.
9. Bradford M. A sensitive method for quantitation of microgram quantities of protein utilizing the principle of dye-binding. Anal Biochem 72: 248-252, 1976.
10. Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophages: implications for cholesterol deposition in atherosclerosis. Ann Rev Biochem 52: 223-261, 1983.
11. Devaraj S, Hugou I, Jialal I. Alpha tocopherol decreases CD36 expression in human monocyte-derived macrophages. J Lipid Res 42: 521-527, 2001.
12. Di Mascio P, Kaiser S, Sies H. Lycopene as the most efficent biological carotenoid single oxygen quencher. Arch Bochem Biophys 274: 532-538, 1989.
13. Furhman B, Elis A, Aviram M. Hypocholesterolemic effect of lycopene and beta carotene is related to suppression of cholesterol synthesis and augmentation of LDL receptor activity in macrophages. Biochem Biophys Res Commun 233: 658-662, 1997.
14. Furhman B, Volkova N, Aviram M. Oxidative stress increases the expression of the CD36 scavenger receptor and the cellular uptake of oxidized low-density lipoprotein in macrophages from atherosclerotic mice: protective role of antioxidants and of paraoxonase. Atherosclerosis 161: 307-316, 2002.
15. Gebicki J, Jurgens G, Esterbauer H. Oxidation of low density lipoprotein in vitro, In: Oxidative Stress, edited by Sies H. New York: Academic, 1991, p. 371-397.
16. Guyton JR, Klemp KF, Mims MP. Altered ultrastructural morphology of self-aggregated low density lipoproteins: coalescence of lipid domains forming droplets and vesicles. J Lipid Res 32: 953-962, 1991.
17. Heber D, Lu QY. Overview of mechanisms of action of lycopene. Exp Biol Med (Maywood) 227: 920-923, 2002.
18. Huang W, Ishii I, Zhang WY, Sonobe M, Kruth HS. PMA activation of macrophages alters macrophage metabolism of aggregated LDL. J Lipid Res 43: 1275-1282, 2002.
19. Jung WJ, Sung MK. Effects of major dietary antioxidants on inflammatory markers of RAW 264.7 macrophages. Biofactors 21: 113-117, 2004.
20. Kok FJ, Kromhout D. Atherosclerosis- epidemiological studies on the health effects of a Mediterranean diet. Eur J Nutr 43, Suppl 1: 2-5, 2004.
21. Kunjathoor VV, Febbraio M, Podrez EA, Moore KJ, Abdersson L, Koehn L, Rhee JS, Siverstein R, Hoff HF, Freeman MW. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of miodificed low density lipoprotein leading to lipid loading in macrophages. J Biol Chem 277: 49982-49988, 2002.
22. Libby P, Geng YJ, Aikawa M, Schoenbeck U, Mach F, Clinton SK, Sukhova GK, Lee RT. Macrophages and atherosclerotic plaque stability. Curr Opin Lipidol 7: 330-335, 1996.
23. Matsuura E, Kobayashi K, Tabuchi M, Lopez LR. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis. Prog Lipid Res 45: 466-486, 2006.
24. Moore EH, Napolitano M, Avella M, Bejta F, Suckling KE, Bravo E, Botham KM. Protection of chylomicron remnants from oxidation by incorporation of probucol into the particles enhances their uptake by human macrophages and increases lipid accumulation in the cells. Eur J Biochem 271: 2417-2427, 2004.
25. Moore EH, Napolitano M, Prosperi A, Avella M, Suckling KE, Bravo E, Botham KM. Incorporation of lycopene into chylomicron remnant-like particles enhances their induction of lipid accumulation in macrophages. Biochem Biophys Res Commun 312: 1216-1219, 2003.
26. Munteanu J, Zingg M, Azzi A. Anti-atherosclerotic effects of vitamin E -myth or reality? J Cell Mol Med 8: 59-76, 2004.
27. Napolitano M, Avanzi L, Manfredi S, Bravo E. Effects of a new combinative antioxidant FeAOX-6 and alpha toctrienol on macrophage atherogenesis-related functions. Vascul Pharmacol 46: 394-405, 2007.
28. Napolitano M, Bravo E. Activation of protein Kinase C by phorbol esters in human macrophages reduces the metabolism of modified LDL by down-regulation of scavenger receptor activity. Int J Biochem Cell Biol 35: 1127-1143, 2002.
29. Napolitano M, Bravo E. Lipid metabolism and TNF-alpha secretion in response to dietary sterols in human monocyte derived macrophages. Eur J Clin Invest 35: 482-490, 2005.
30. Ohashi R, Mu H, Wang X, Yao Q, Chen C. Reverse cholesterol transport and cholesterol efflux in atherosclerosis. Q J Med 98: 845-856, 2005.
31. Persson J, Nilsson J, Lindholm MW. Cytokine response to lipoprotein loading in human monocyte-derived macrophages (Abstract). Lipids Health Dis 5: 17, 2006.
32. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2: 2002-2007, 2001.
33. Rao AV, Ray MR, Rao LG. Lycopene. Adv Food Nutr Res 51: 99-164, 2006.
34. Rao AV, Agarwal S. Bioavailability and in vivo antioxidant properties of lycopene from tomato products and their possible role in the prevention of cancer. Nutr Cancer 31: 199-203, 1998.
35. Riso P, Visioli F, Grande S, Guarnieri S, Gardana C, Simonetti P, Porrini M. Effect of a tomato-based drink on markers of inflammation, immunomodulation and oxidative stress. J Agric Food Chem 54: 2563-2566, 2006.
36. Robbeysin F, Salvayre R, Negre-Salvayre A. Dual role of oxidized LDL on the NK-kappaB signalling pathway. Free Rad Res 38: 541-551, 2004.
37. Sesso HD. Carotenoids and cardiovascular disease:what research gaps remain? Curr Opin Lipidol 17: 11-16, 2006.
38. Shige H, Ishikawa T, Suzukawa M, Nishiwaki M, Yamashita T, Nakajima K, Ito T, Higashi K, Ayaori M, Yonemura A, Nestel P, Nakamura H. Vitamin E reduces cholesterol esterification and uptake of acetylated low density lipoprotein in macrophages. Lipids 33: 1169-1175, 1998.
39. Singh U, Deveraj S, Jialal I. Vitamin E, oxidative stress and inflammation. Annu Rev Nutr 25: 151-174, 2005.
40. Steinberg D. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med 8: 1211-1217, 2002.
41. Suzukawa M, Abbey M, Clifton P, Nestel PJ. Effects of supplementing with vitamin E on the uptake of low density lipoprotein and the stimulation of cholesteryl ester formation in macrophages. Atherosclerosis 110: 77-86, 1994.
42. Suzuki H, Kurihara Y, Takeya M, Kamada N, Kataoka M, Jishage K, Sakaguchi H, Kruijt JK, Higashi T, Suzuki T, van Berkel TJ, Horiuchi S, Takahashi K, Yazaki Y, Kodama T. The multiple roles of macrophage scavenger receptors (MSR) in vivo: resistance to atherosclerosis and susceptibility to infection in MSR knockout mice. J Atheroscler Thromb 4: 1-11, 1997.
43. Takemura T, Sakai M, Matsuda H, Matsumura T, Biwa T, Anami Y, Nishikawa T, Sasahara T, Shichiri M. Effects of probucol on cholesterol metabolism in mouse peritoneal macrophages: inhibition of HDL mediated cholesterol efflux. Atherosclerosis 152: 347-357, 2000.
44. Teupser J, Thiery D, Seidel D. α-Tocopherol down-regulates scavenger receptor activity in macrophages. Atherosclerosis 144: 109-115, 1999.
45. Trach CC, Wulfroth PM, Severs NJ, Robenek H. Influence of native and modified lipoproteins on migration of mouse peritoneal macrophages and the effect of the antioxidants vitamin E and probucol. Eur J Cell Biol 71: 199-205, 1996.
46. Vainio S, Ikonen E. Macrophage cholesterol transport: a critical player in foam cell formation. Ann Med 35: 146-155, 2003.
47. Voutilainen S, Nurmi T, Mursu J, Rissanen TH. Carotenoids and cardiovascular health. Am J Clin Nutr 83: 1265-1271, 2006.
48. Yamamoto A, Hara H, Takaichi S, Wakasugi S, Tomikawa M. Effect of probucol on macrophages, leading to regression of xanthomas and atheromatous vascular lesions. Am J Cardiol 62: 31B-36B, 1988.